| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.27 | 0.2 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.29 | 0.2 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.28 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |